Evidence map›Paper›PMID 42453142›Full record

ArticleBMC methods2026

A simple and versatile fluorescence-based method to enhance prime editing in human pluripotent stem cells.

Carlye Frisch, Salma Leyasi, William W Kostes, Stefan J Tekel, Kylie Standage-Beier, Gayathri Srinivasan, Xiao Wang, David A Brafman

Abstract read
In one paragraph

Article in BMC methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlye FrischSchool for Engineering of Matter, Transport and Energy, Arizona State University, Tempe AZ 85287, USA.
Salma LeyasiSchool for Engineering of Matter, Transport and Energy, Arizona State University, Tempe AZ 85287, USA.
William W KostesSchool of Biological and Health Systems Engineering, Arizona State University, 501 E. Tyler Mall, ECG 334A, Tempe AZ 85287, USA.
Stefan J TekelSchool of Biological and Health Systems Engineering, Arizona State University, 501 E. Tyler Mall, ECG 334A, Tempe AZ 85287, USA.
Kylie Standage-BeierSchool of Biological and Health Systems Engineering, Arizona State University, 501 E. Tyler Mall, ECG 334A, Tempe AZ 85287, USA.
Gayathri SrinivasanSchool of Biological and Health Systems Engineering, Arizona State University, 501 E. Tyler Mall, ECG 334A, Tempe AZ 85287, USA.
Xiao WangSchool of Biological and Health Systems Engineering, Arizona State University, 501 E. Tyler Mall, ECG 334A, Tempe AZ 85287, USA.
David A BrafmanSchool of Biological and Health Systems Engineering, Arizona State University, 501 E. Tyler Mall, ECG 334A, Tempe AZ 85287, USA.

Funding

Investigating the mechanisms of a multi-state model of Wnt signalingR01GM121698 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2017 to 2021
$1.7M
Forward engineering to understand gene regulatory network topologiesR01GM106081 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, XIAO · 2014 to 2018
$1.7M
Model-guided design of RNA stabilizing elements for improved coronavirus diagnosticsR01EB031893 · NIBIB · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI GREEN, ALEXANDER ARTHUR, WANG, XIAO · 2021 to 2022
$1.3M
BD FACSymphony S6 cell sorterS10OD032287 · OD · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2022 to 2022
$599k
Elucidating the protective effects of the KL-VS variant using isogenic hiPSCsR21AG075612 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2022 to 2022
$432k
Establishing Genotype-to-Phenotype Relationships Between Alzheimer’s Related BIN1 VariantsR21AG079279 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2022 to 2022
$432k
Investigating an African American-specific APOE genetic variant using hiPSCR21AG085395 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2024 to 2025
$432k
Dissecting the interaction between sex and APOE genotype in modulating AD riskR21AG085470 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2024 to 2024
$432k
Generation and characterization of isogenic hiPSC lines with various APOE genotypesR21AG056706 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BRAFMAN, DAVID A · 2017 to 2018
$409k
NIA NIH HHS R21 AG056706NIA NIH HHS R21 AG075612NIA NIH HHS R21 AG079279NIA NIH HHS R21 AG085395NIA NIH HHS R21 AG085470NIBIB NIH HHS R01 EB031893NIGMS NIH HHS R01 GM106081NIGMS NIH HHS R01 GM121698NIH HHS S10 OD032287
6 · The paper itself

Abstract

Background: Prime editing is a versatile and precise genome-editing technique that enables targeted modifications with unprecedented accuracy. Unlike other CRISPR-based methods, prime editing does not induce double-stranded DNA breaks, thereby minimizing genomic instability and off-target effects. This technology allows for precise insertions, deletions, and substitutions, surpassing the limitations of conventional genome-editing approaches. However, a major challenge remains-low editing efficiency in human pluripotent stem cells (hPSCs), which restricts its broader application in stem cell research and regenerative medicine. Methods: This protocol describes Prime-Induced Nucleotide Engineering using a Transient Reporter for Editing Enrichment (PINE-TREE), a fluorescence-based system designed to enhance prime editing efficiency in hPSCs. The step-by-step methodology details plasmid construction, transfection, and clonal isolation strategies, facilitating real-time enrichment of prime-edited cells. Additionally, the protocol includes comprehensive methods for evaluating off-target effects and confirming the maintenance of pluripotency, ensuring precision and reliability in edited cell lines. Discussion: PINE-TREE significantly improves the efficiency of prime editing in hPSCs, addressing key limitations associated with low editing rates. By enabling real-time fluorescence-based enrichment, this system enhances the isolation of successfully edited cells, reducing the need for labor-intensive selection processes. Moreover, its adaptability across multiple cell types and compatibility with various prime editing strategies make it a valuable tool for researchers in genome engineering, disease modeling, and regenerative medicine. Clinical trial number: Not applicable.

Indexed as

CRISPRDNAFluorescent reporterGenome modificationHuman pluripotent stem cellsInduced pluripotent stem cellsPrime editingRNA

Identifiers

PMID42453142
PMCPMC13367918

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.